Contract
H6622
Humana · 2027 Star Ratings
HUMANA WI HEALTH ORGANIZATION INSURANCE CORP · Local CCP · offers special needs plans
Parent: Humana Inc.
Summary ratings
Overall
4.0
2026: 3.5+0.5
Part C · health plan
4.0
2026: 3.5+0.5
Part D · drug plan
4.0
2026: 3.5+0.5
2027 footprint
- Members, Sep 2026
- 332K
- 2027 plans
- 53
- Open to all ($0 premium)
- 37 (33)
- Counties
- 403
- Special needs plans
- Chronic or Disabling Condition, Dual-Eligible
- Drug coverage
- Yes
KYMDMSMTNCNJNVOHOKPAVAWI
Domain stars
| Domain | 2027 | 2026 | Change |
|---|---|---|---|
| HD1Staying Healthy: Screenings, Tests and Vaccines | 3.0 | 4.0 | −1.0 |
| HD2Managing Chronic (Long Term) Conditions | 4.0 | 4.0 | ±0 |
| HD3Member Experience with Health Plan | 4.0 | 3.0 | +1.0 |
| HD4Member Complaints and Changes in the Health Plan's Performance | 4.0 | 4.0 | ±0 |
| HD5Health Plan Customer Service | 4.0 | 4.0 | ±0 |
| DD1Drug Plan Customer Service | 5.0 | 5.0 | ±0 |
| DD2Member Complaints and Changes in the Drug Plan's Performance | 4.0 | 4.0 | ±0 |
| DD3Member Experience with the Drug Plan | Not enough data available | 4.0 | — |
| DD4Drug Safety and Accuracy of Drug Pricing | 3.0 | 3.0 | ±0 |
Part C measures · health plan
| Measure | 2027 result | 2027 stars | vs 2026 |
|---|---|---|---|
| C01Breast Cancer Screening | 75% | 3.0 | ±0 |
| C02Colorectal Cancer Screening | 77% | 4.0 | new spec |
| C03Annual Flu Vaccine | 65% | 3.0 | ±0 |
| C04Improving or Maintaining Physical Health | 66% | 1.0 | −3 |
| C05Improving or Maintaining Mental Health | Not enough data available | — | |
| C06Monitoring Physical Activity | 53% | 3.0 | ±0 |
| C07Special Needs Plan (SNP) Care Management | 80% | 4.0 | ±0 |
| C08Care for Older Adults – Medication Review | 98% | 4.0 | ±0 |
| C09Care for Older Adults - Functional Status Assessment | 95% | 5.0 | — |
| C10Osteoporosis Management in Women who had a Fracture | 47% | 3.0 | ±0 |
| C11Diabetes Care – Eye Exam | 80% | 4.0 | ±0 |
| C12Diabetes Care – Blood Sugar Controlled | 91% | 4.0 | ±0 |
| C13Kidney Health Evaluation for Patients with Diabetes | 74% | 4.0 | ±0 |
| C14Controlling High Blood Pressure | 85% | 4.0 | ±0 |
| C15Reducing the Risk of Falling | 61% | 3.0 | +1 |
| C16Improving Bladder Control | 47% | 4.0 | +2 |
| C17Plan All-Cause Readmissions | 11% | 3.0 | ±0 |
| C18Statin Therapy for Patients with Cardiovascular Disease | 91% | 4.0 | ±0 |
| C19Transitions of Care | 76% | 4.0 | ±0 |
| C20Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions | 62% | 2.0 | ±0 |
| C21Getting Needed Care | 83 | 4.0 | +2 |
| C22Getting Appointments and Care Quickly | Not enough data available | — | |
| C23Customer Service | 90 | 3.0 | +1 |
| C24Rating of Health Care Quality | 88 | 4.0 | ±0 |
| C25Rating of Health Plan | 88 | 4.0 | +2 |
| C26Care Coordination | 88 | 4.0 | ±0 |
| C27Complaints about the Health Plan | 0.2 | 4.0 | ±0 |
| C28Members Choosing to Leave the Plan | 22% | 3.0 | ±0 |
| C29Health Plan Quality Improvement | Medicare shows only a Star Rating for this topic | 4.0 | ±0 |
| C30Plan Makes Timely Decisions about Appeals | 99% | 4.0 | ±0 |
| C31Reviewing Appeals Decisions | 99% | 4.0 | ±0 |
| C32Call Center – Foreign Language Interpreter and TTY Availability | 100% | 5.0 | ±0 |
Part D measures · drug plan
| Measure | 2027 result | 2027 stars | vs 2026 |
|---|---|---|---|
| D01Call Center – Foreign Language Interpreter and TTY Availability | 100% | 5.0 | ±0 |
| D02Complaints about the Drug Plan | 0.2 | 4.0 | ±0 |
| D03Members Choosing to Leave the Plan | 22% | 3.0 | ±0 |
| D04Drug Plan Quality Improvement | Medicare shows only a Star Rating for this topic | 5.0 | +1 |
| D05Rating of Drug Plan | 89 | 4.0 | ±0 |
| D06Getting Needed Prescription Drugs | Not enough data available | — | |
| D07MPF Price Accuracy | 93 | 1.0 | ±0 |
| D08Medication Adherence for Diabetes Medications | 89% | 3.0 | ±0 |
| D09Medication Adherence for Hypertension (RAS antagonists) | 91% | 4.0 | +1 |
| D10Medication Adherence for Cholesterol (Statins) | 90% | 4.0 | +1 |
| D11Statin Use in Persons with Diabetes (SUPD) | 89% | 3.0 | ±0 |
| D12Concurrent Use of Opioids and Benzodiazepines (COB) | 9% | 4.0 | — |
| D13Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH) | 5% | 5.0 | — |